MedPath

Lidocaine-Prilocaine Cream in Conjunction With Paracervical Block for Pain With Abortion

Phase 3
Withdrawn
Conditions
Pain
Interventions
Drug: Lidocaine-Prilocaine Cream
Drug: Placebo Cream
Drug: 1% Lidocaine Paracervical Block
Registration Number
NCT03508804
Lead Sponsor
Stanford University
Brief Summary

The investigators theorize that the application of a lidocaine-prilocaine cream 5-10 minutes prior to the administration of a paracervical block could decrease pain associated with its administration and pain with abortion overall.

Detailed Description

This is a superiority, double-blind randomized controlled trail of women ages 18 and older presenting for first-trimester surgical abortion. The lidocaine-prilocaine cream will be used in the experimental group in conjunction with a paracervical block, whereas plain lubricating gel will be used in conjunction with a paracervical block for the placebo, control group.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria
  • surgical abortion patient at 5 0/7 to 11 6/7 weeks gestational age;
  • English or Spanish speaking;
  • ability to give informed consent
Read More
Exclusion Criteria
  • pre-operative use of misoprostol;
  • allergy to study medications (lidocaine, prilocaine, versed, fentanyl);
  • known uterine anomaly;
  • prior cervical surgery
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placebo cream (pain lucubrating gel)1% Lidocaine Paracervical Block5-10 minutes prior to the start of the procedure, the participant will self-administer 10ml of the placebo cream vaginally using a syringe
Lidocaine-prilocaine creamLidocaine-Prilocaine Cream5-10 minutes prior to the start of the procedure, the participant will self-administer 10ml of the lidocaine-prilocaine cream vaginally using a syringe
Lidocaine-prilocaine cream1% Lidocaine Paracervical Block5-10 minutes prior to the start of the procedure, the participant will self-administer 10ml of the lidocaine-prilocaine cream vaginally using a syringe
Placebo cream (pain lucubrating gel)Placebo Cream5-10 minutes prior to the start of the procedure, the participant will self-administer 10ml of the placebo cream vaginally using a syringe
Primary Outcome Measures
NameTimeMethod
Pain perceived as measured by a Visual Analog Scale (0-100mm) at the time of cervical dilationIntraoperative; Immediately following cervical dilation
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Stanford Health Care

🇺🇸

Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath